Thanks for the reminder of what Jeff said because at the time I thought there was something a bit unsettling about it and now I know why. Why is it left until the pointy end of the 2nd technology deal for the company to turn it's mind to the issue of getting the revenue structure right with the P&G commercial relationship? Surely this is something that should have been mapped out and settled when OBJ went into negotiations for the master licensing agreement more than 2 years ago. Isn't this what Steve Meller was for? And here we are NOW with the company trying to work out how to make a profit from P&G, four product launches later. This is the very reason why I think a new chairman and additional directors need to be appointed now - executives that will have the commercial foresight to plan well ahead to ensure that our remarkable company sees significant revenues being secured that are commensurate with the company's ground breaking technology. We presently don't have that and consequently we are now witnessing what appears be have been a lack of proficiency in securing just commercial entitlements for the company.
- Forums
- ASX - By Stock
- WFL
- Higher base price before 2nd tech ann
Higher base price before 2nd tech ann, page-39
-
-
- There are more pages in this discussion • 92 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online